Publikationen in Zusammenarbeit mit Forschern von Instituto de Parasitología y Biomedicina López Neyra (24)

2024

  1. Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants

    npj Genomic Medicine, Vol. 9, Núm. 1

  2. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

    The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383

  3. Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4+ T cells in giant cell arteritis

    Journal of Autoimmunity, Vol. 142

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

2021

  1. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

    Nature Communications, Vol. 12, Núm. 1

  2. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

    Scientific Reports, Vol. 11, Núm. 1

2014

  1. Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82

  2. Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: A genome-wide association study replication and meta-analysis

    Arthritis Research and Therapy, Vol. 16, Núm. 2

2013

  1. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886

  2. Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease

    Human Immunology, Vol. 74, Núm. 2, pp. 230-233

2012

  1. NPSR1 gene is associated with reduced risk of rheumatoid arthritis

    Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1166-1170

2011

  1. Evidence for PTPN22 R620W polymorphism as the sole common risk variant for rheumatoid arthritis in the 1p13.2 region

    Journal of Rheumatology, Vol. 38, Núm. 11, pp. 2290-2296

  2. No evidence of association of the KLF12 gene with rheumatoid arthritis in Spanish and Dutch cohorts and a meta-analysis of published data

    Human Immunology, Vol. 72, Núm. 9, pp. 779-782

  3. The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples

    Arthritis and Rheumatism, Vol. 63, Núm. 2, pp. 365-372

2010

  1. Association study of ghrelin receptor gene polymorphisms in rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 1, pp. 25-29

  2. Deletion of the late cornified envelope genes, LCE3C and LCE3B, is associated with rheumatoid arthritis

    Arthritis and Rheumatism, Vol. 62, Núm. 5, pp. 1246-1251

  3. Identification of HAVCR1 gene haplotypes associated with mRNA expression levels and susceptibility to autoimmune diseases

    Human Genetics, Vol. 128, Núm. 2, pp. 221-229

  4. Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis

    Arthritis and Rheumatism, Vol. 62, Núm. 11, pp. 3183-3190

2008

  1. Investigation of CD69 as a new candidate gene for rheumatoid arthritis

    Tissue Antigens, Vol. 72, Núm. 3, pp. 206-210

  2. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1451-1454